NovaBridge Biosciences
NBP · NASDAQ
$1.43+$0.125 (+9.62%)TodayMarket closed ·
Prev close $1.30
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 40.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q4 FY25 | -$0.053 | -$0.29 | −447.2% |
| Q3 FY25 | -$0.048 | -$0.03 | +37.5% |
| Q2 FY25 | -$0.0404 | -$0.066 | −63.4% |
| Q1 FY25 | -$0.0657 | -$0.03 | +54.3% |
| Q4 FY24 | -$0.0572 | -$0.08 | −39.9% |
| Q3 FY24 | -$0.2344 | -$0.25 | −6.7% |
| Q2 FY24 | -$1.31 | -$0.46 | +65.0% |
| Q1 FY24 | -$0.2218 | -$0.21 | +5.3% |
Earnings calls
- NBP - Earnings call Q2 2026
- Special Call - NovaBridge Biosciences
- Mab - Special Call - I-Mab
- Mab - Special Call - I-Mab
- I-Mab, H1 2024 Earnings Call, Aug 28, 2024
- I-Mab, H1 2023 Earnings Call, Aug 17, 2023
- Earnings call Q2 2023
- Earnings call Q4 2022
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.